Berti, Alvise
 Distribuzione geografica
Continente #
NA - Nord America 4.643
AS - Asia 3.506
EU - Europa 2.115
SA - Sud America 778
Continente sconosciuto - Info sul continente non disponibili 390
AF - Africa 94
OC - Oceania 20
Totale 11.546
Nazione #
US - Stati Uniti d'America 4.465
SG - Singapore 1.232
IT - Italia 927
CN - Cina 663
BR - Brasile 603
VN - Vietnam 600
HK - Hong Kong 240
RU - Federazione Russa 239
BD - Bangladesh 194
GB - Regno Unito 150
FR - Francia 143
KR - Corea 131
DE - Germania 125
LV - Lettonia 119
IN - India 113
FI - Finlandia 108
CA - Canada 96
NL - Olanda 87
ID - Indonesia 80
AR - Argentina 62
EC - Ecuador 47
SE - Svezia 46
JP - Giappone 41
MX - Messico 40
AT - Austria 34
ES - Italia 34
ZA - Sudafrica 26
CO - Colombia 25
IQ - Iraq 24
TR - Turchia 24
PK - Pakistan 19
UA - Ucraina 19
SA - Arabia Saudita 18
AU - Australia 17
MA - Marocco 17
PL - Polonia 17
IR - Iran 16
VE - Venezuela 14
EG - Egitto 13
IE - Irlanda 13
MY - Malesia 13
TW - Taiwan 13
PH - Filippine 12
CL - Cile 10
AE - Emirati Arabi Uniti 9
CH - Svizzera 9
JM - Giamaica 9
TN - Tunisia 9
BE - Belgio 8
PS - Palestinian Territory 8
AZ - Azerbaigian 7
DZ - Algeria 7
KE - Kenya 7
NP - Nepal 7
PY - Paraguay 7
JO - Giordania 6
TH - Thailandia 6
TT - Trinidad e Tobago 6
UZ - Uzbekistan 6
CR - Costa Rica 5
DO - Repubblica Dominicana 5
KZ - Kazakistan 5
LT - Lituania 5
PE - Perù 5
CI - Costa d'Avorio 4
CZ - Repubblica Ceca 4
ET - Etiopia 4
LB - Libano 4
AD - Andorra 3
GT - Guatemala 3
IL - Israele 3
LK - Sri Lanka 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
QA - Qatar 3
AL - Albania 2
BB - Barbados 2
BO - Bolivia 2
BS - Bahamas 2
EE - Estonia 2
GE - Georgia 2
GY - Guiana 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
MD - Moldavia 2
OM - Oman 2
PR - Porto Rico 2
RS - Serbia 2
SN - Senegal 2
SV - El Salvador 2
AI - Anguilla 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CD - Congo 1
CU - Cuba 1
DJ - Gibuti 1
DK - Danimarca 1
Totale 11.145
Città #
Singapore 808
Ashburn 739
San Jose 658
Santa Clara 337
Columbus 310
Trento 268
Dallas 251
Hong Kong 214
Ho Chi Minh City 182
Council Bluffs 176
New York 142
Phoenix 140
Hanoi 131
Moscow 126
Los Angeles 125
Seoul 125
Milan 122
Riga 119
Hefei 103
Lauterbourg 100
Beijing 89
Helsinki 72
Rome 64
Buffalo 62
The Dalles 54
São Paulo 49
Redondo Beach 39
Chicago 38
Boardman 37
Jakarta 36
Da Nang 32
Orem 32
Rio de Janeiro 31
Secaucus 31
Haiphong 27
Montreal 27
Washington 27
Brooklyn 26
Lappeenranta 26
Tokyo 25
Toronto 25
Riverside 24
London 23
Munich 22
Nuremberg 22
San Francisco 22
Naples 21
Can Tho 20
Stockholm 20
Frankfurt am Main 19
Manchester 19
Chennai 18
Mexico City 18
Mesa 17
Shanghai 17
Atlanta 16
Miano 16
Quito 16
Vienna 16
Biên Hòa 15
Bologna 15
Boston 15
Bắc Ninh 15
Castello Molina di Fiemme 15
Groningen 15
Guangzhou 15
Gurugram 15
Hyderabad 15
Warsaw 15
Guayaquil 14
Amsterdam 13
Brasília 13
Houston 13
Hải Dương 13
Johannesburg 13
Tampa 13
Ogden 12
Thái Bình 12
Turin 12
Denver 11
Falkenstein 11
Kilburn 11
Paris 11
Poplar 11
Salt Lake City 11
Wilmington 11
Baghdad 10
Mumbai 10
Pamplona 10
St Louis 10
Turku 10
Agrolândia 9
Belo Horizonte 9
Buenos Aires 9
Dublin 9
Figino 9
Istanbul 9
Ninh Bình 9
Palermo 9
Porto Alegre 9
Totale 6.857
Nome #
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update 237
Autoreactive B Cells in ANCA-Associated Vasculitis 227
Off-label use of biologics in urticarial vasculitis: a European retrospective cohort study 200
Small airway dysfunction and impulse oscillometry in adult patients with asthma: recent findings 195
Identification of the central tolerance checkpoint for autoreactive proteinase 3+ B cells in human bone marrow 178
Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis 159
Severe asthma: One disease and multiple definitions 155
Diamine Oxidase Supplementation in Chronic Spontaneous Urticaria: A Randomized, Double-Blind Placebo-Controlled Study 153
Aging in Granulomatosis with Polyangiitis and Microscopic Polyangiitis: From Pathophysiology to Clinical Management 153
Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative study 152
Impulse oscillometry for the evaluation and management of pediatric asthma 151
Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank 146
A glance into the future of anti-neutrophil cytoplasmic antibody-associated vasculitis 143
Immune-Related Adverse Events Due to Cancer Immunotherapy: Immune Mechanisms and Clinical Manifestations 140
Outer membrane vesicles from the gut microbiome contribute to tumor immunity by eliciting cross-reactive T cells 137
Small airway dysfunction mediates the relationship between Fractional Exhaled Nitric Oxide and asthma control 130
Small airway dysfunction and obesity in asthmatic patients: a dangerous liaison? 127
Autoreactive Plasmablasts After B Cell Depletion With Rituximab and Relapses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis 120
Anti-Tumor Efficacy of In Situ Vaccination Using Bacterial Outer Membrane Vesicles 117
Interleukin-6 in ANCA-associated Vasculitis: Rationale for Successful Treatment With Tocilizumab 117
Identification and phenotyping of circulating autoreactive proteinase 3-specific B cells in patients with PR3-ANCA associated vasculitis and healthy controls 117
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 116
The emerging roles of eosinophils: Implications for the targeted treatment of eosinophilic-associated inflammatory conditions 115
Clinical Characterization and Predictors of IOS-Defined Small-Airway Dysfunction in Asthma. 111
Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the Lifespan 111
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire 110
Ear, nose and throat involvement in granulomatosis with polyangiitis: how it presents and how it determines disease severity and long-term outcomes 110
Anti-neutrophil cytoplasmic antibody specificity determines a different clinical subset in granulomatosis with polyangiitis 110
Disease and Treatment-Related Morbidity in Young and Elderly Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis 106
Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim-Chester disease 105
Advances in the pharmacotherapeutic management of eosinophilic granulomatosis with polyangiitis 105
Asthma and COVID-19: a dangerous liaison? 104
Very long-term data on patients with severe eosinophilic asthma treated with mepolizumab: a case series 101
Asthma control in eosinophilic granulomatosis with polyangiitis treated with rituximab 100
Health Literacy and Outcomes Among Patients With Heart Failure: A Systematic Review and Meta-Analysis 100
Aging in Primary Systemic Vasculitis: Implications for Diagnosis, Clinical Manifestations, and Management 99
Oscillometry-defined small airways dysfunction as a treatable trait in asthma 99
Risk of cardiovascular toxicity with combination of immune-checkpoint inhibitors and angiogenesis inhibitors: a meta-analysis 98
Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. 98
Practical approach to vasculitides in adults: an overview of clinical conditions that can mimic vasculitides closely 98
Efficacy and safety of biological agents in adult-onset Still's disease 97
Outer Membrane Vesicles From The Gut Microbiome Contribute to Tumor Immunity by Eliciting Cross-Reactive T Cells 97
Efficacy of rituximab and plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis with severe kidney disease 96
Osteoporosis and fractures in systemic vasculitides: a systematic review and meta-analysis 96
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 95
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study 95
Diagnosing and treating ANCA-Associated vasculitis: An updated review for clinical practice 94
Kaposi's Sarcoma in a Patient With Eosinophilic Granulomatosis With Polyangiitis While Taking Mycophenolate Mofetil 93
Immune and cellular damage biomarkers to predict COVID-19 mortality in hospitalized patients 92
Aortic thrombosis secondary to clopidogrel-related thrombotic thrombocytopenic purpura 91
Allergic rhinitis and COVID-19: friends or foes? 90
Association of Smoking and Obesity on the Risk of Developing Primary Sjögren Syndrome: A Population-based Cohort Study 89
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life 88
Risk of Cardiovascular Disease and Venous Thromboembolism Among Patients With Incident ANCA-Associated Vasculitis: A 20-Year Population-Based Cohort Study 88
Authors' response 86
Eosinophilic granulomatosis with polyangiitis: the multifaceted spectrum of clinical manifestations at different stages of the disease 85
Remission maintenance in ANCA-associated vasculitis: does one size fit all? 85
Incidence, prevalence, mortality and chronic renal damage of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in a 20-year population-based cohort 85
Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre study 85
Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for Rheumatology 85
Characterizing the preserved ratio impaired spirometry phenotype in all severities of asthma 85
Treatment Approaches to Granulomatosis with Polyangiitis and Microscopic Polyangiitis 84
Eosinophilic Granulomatosis With Polyangiitis: Clinical Predictors of Long-term Asthma Severity 84
Prevalence and features of IOS-defined small airway disease across asthma severities 84
Small Airways: The “Silent Zone” of 2021 GINA Report? 83
Disease trends over time and CD4 + CCR5 + T-cells expansion predict carotid atherosclerosis development in patients with systemic lupus erythematosus 83
Erdheim-Chester disease 82
Tocilizumab in patients with multisystem Erdheim-Chester disease 81
Cardiovascular manifestations of Erdheim-Chester disease 81
Induction and maintenance of remission with mycophenolate mofetil in ANCA-associated vasculitis: a systematic review and meta-analysis 81
A second case of pericardial mesothelioma mimicking systemic lupus erythematosus in the literature in over 30 years: a case report 81
Myositis and myasthenia during nivolumab administration for advanced lung cancer: a case report and review of the literature 81
Circulating autoreactive proteinase 3+ B cells and tolerance checkpoints in ANCA-associated vasculitis 81
Clinical picture, outcomes, and predictors of relapse in eosinophilia-associated coronary vasospasm: Data from a European multicentric study 80
Giant cell arteritis restricted to the limb arteries: An overlooked clinical entity 80
Severe/uncontrolled Asthma and Overall Survival in Atopic Patients With Eosinophilic Granulomatosis With Polyangiitis 79
Correction to: Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the Lifespan (Drugs, (2024), 84, 6, (661-684), 10.1007/s40265-024-02037-0) 77
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease. 76
Small-airway dysfunction in paediatric asthma 75
Psychometric properties of outcome measurement instruments for ANCA-associated vasculitis: A systematic literature review 75
Patients with breakthrough reactions to iodinated contrast media have low incidence of positive skin tests 74
Proposal of a skin tests based approach for the prevention of recurrent hypersensitivity reactions to iodinated contrast media 72
Histamine release positive test associates with disease remission in chronic spontaneous urticaria: a proof-of-concept study 72
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study 72
The association of serum interleukin-6 levels with clinical outcomes in antineutrophil cytoplasmic antibody-associated vasculitis 72
Meta-analysis of immune-related adverse events in phase 3 clinical trials assessing immune checkpoint inhibitors for lung cancer 72
Monoclonal antibodies targeting small airways: a new perspective for biological therapies in severe asthma 71
Chronic Rhinosinusitis in Eosinophilic Granulomatosis With Polyangiitis: Clinical Presentation and Antineutrophil Cytoplasmic Antibodies 71
Update on the epidemiology, risk factors, and outcomes of systemic vasculitides 71
Drug induced exfoliative dermatitis: state of the art. 70
Dupilumab reduces patient-reported cough and improves quality of life in patients with severe eosinophilic asthma with or without chronic rhinosinusitis with nasal polyps: a real-life prospective study 69
Hypertrophic Cardiomyopathy Secondary to Hepatitis C Virus-Related Vasculitis 68
BRAFV600E-mutation Is Invariably Present and Associated to Oncogene-Induced Senescence in Erdheim-Chester Disease 68
Targeting the interleukin-5 pathway in EGPA: Evidence, uncertainties and opportunities 67
Juxta-vertebral lesions in granulomatosis with polyangiitis 67
Obesity is a Major Risk Factor for Hospitalization in Community-Managed COVID-19 Pneumonia 67
Measurement Properties of Outcome Instruments for Large-Vessel Vasculitis: A Systematic Literature Review 66
Assessment Of Tocilizumab In The Treatment Of Cancer Cachexia 66
Predicting Disease Activity in Systemic Vasculitides: On the Hunt for Potential Candidates 65
EBV-induced lymphoproliferative disorders in rheumatic patients: A systematic review of the literature 65
Totale 10.060
Categoria #
all - tutte 49.027
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 173
Totale 49.200


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202237 0 0 0 2 9 3 2 7 2 5 3 4
2022/2023328 4 0 0 1 0 0 0 0 0 123 107 93
2023/2024322 1 1 32 13 53 83 27 12 3 27 19 51
2024/20252.850 64 22 307 499 157 303 37 97 221 298 245 600
2025/20266.020 282 201 705 1.036 570 324 1.013 145 513 460 343 428
2026/20271.989 299 408 731 551 0 0 0 0 0 0 0 0
Totale 11.546